Kidney Technology Development Research Education Program (R25 Clinical Trial Not Allowed)

The summary for the Kidney Technology Development Research Education Program (R25 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Kidney Technology Development Research Education Program (R25 Clinical Trial Not Allowed): The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this R25 program is to support educational activities that help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral and clinical sciences.
Federal Grant Title: Kidney Technology Development Research Education Program (R25 Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Food and Nutrition Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DK-19-006
Type of Funding: Grant
CFDA Numbers: 93.847
CFDA Descriptions: Information not provided
Current Application Deadline: August 6th, 2019
Original Application Deadline: August 6th, 2019
Posted Date: March 11th, 2019
Creation Date: March 11th, 2019
Archive Date: September 11th, 2019
Total Program Funding: $550,000
Maximum Federal Grant Award: $130,000
Minimum Federal Grant Award:
Expected Number of Awards: 4
Cost Sharing or Matching: No
Last Updated: March 11th, 2019
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-006.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NI...
Adipogenesis, Adipocyte Function and Obesity Following HIV Infection, Antiretroviral Thera...
Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Tri...
Limited Competition: Follow-up on Subjects, Integrative Data Analysis and Measurement of V...
Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
Molecular Therapy Core Centers
Pilot and Feasibility Program in Human Islet Biology
More Grants from the National Institutes of Health
NIA Program Project Applications (P01 Clinical Trial Optional)
Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional)
Specialized Alcohol Research Centers (P50 Clinical trial Optional)
Population Dynamics Centers Research Infrastructure Program FY 2020 (P2C Clinical Trial No...
Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Cl...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com